# OnCo record ugn-104 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ugn-104/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ugn-104" ;
  schema:name "UGN-104"@en ;
  schema:alternateName "UGN-104 (mitomycin) for pyelocalyceal solution"@en ;
  schema:description "UGN-104 is an experimental chemotherapy (mitomycin) delivered via hydrogel from UroGen Pharma in phase 3 trials for bladder & urothelial cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/ugn-104/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=UGN-104>, <https://www.urogen.com/pipeline> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "chemotherapy (mitomycin) delivered via hydrogel" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:companies <https://onco.cc/companies/urogen-pharma/> ;
  onco:trials <https://onco.cc/trials/nct06774131/> .